Gender differences in multiple sclerosis: Cytokines and vitamin D

Journal of the Neurological Sciences

Volumn 286, Issue 1-2, 2009, Pages 40-42

  Eikelenboom, M J ^a   Killestein, J ^a   Kragt, J J ^a   Uitdehaag, B M J ^a   Polman, C H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Gender differences; Immune system; Multiple sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CYTOKINE; ESTRIOL; ESTROGEN; GAMMA INTERFERON; INTERFERON BETA SERINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ESTROGEN THERAPY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GEOGRAPHIC DISTRIBUTION; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOTHERAPY; INCIDENCE; INFLAMMATORY DISEASE; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SEASONAL VARIATION; SEX DIFFERENCE; SUN EXPOSURE; T LYMPHOCYTE ACTIVATION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

AGE FACTORS; AGE OF ONSET; CYTOKINES; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; SEX FACTORS; VITAMIN D;

EID: 70349777295     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.06.025     Document Type: Article

References (31)

1. Alonso A., and Hernán M.A. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71 (2008) 129-135
2. Debouverie M., Pittion-Vouyovitch S., Louis S., Guillemin F., and LORSEP Group. Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 15 (2008) 916-921
3. Convraveux C., Vukusic S., and Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003) 770-782
4. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C., and Bastianello S. 'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 10 (2003) 95-97
5. Tomassini V., Onesti E., Mainero C., Giugni E., Paolillo A., Salvetti M., et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 76 (2005) 272-275
6. Confraveux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., and Moreau T. Rate of pregnancy relapse in multiple sclerosis: pregnancy in MS group. N Engl J Med 339 (1998) 285-291
7. Alonso A., Jick S.S., Olek M.J., Ascherio A., Jick H., and Hernán M.A. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62 (2005) 1362-1365
8. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., and Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 7 (2008) 626-630
9. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2 (2001) 777-780
10. Whitacre C.C., Reingold S.C., and O'Looney P.A. A gender gap in autoimmunity. Science 283 (1999) 1277-1278
11. Offner H., and Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 1089 (2006) 343-372
12. Hill K.E., Pigmans M., Fujinami R.S., and Rose J.W. Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J Neuroimmunol 85 (1998) 44-51
13. Gilmore W., Weiner L.P., and Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 158 (1997) 446-451
14. Kantarci O.H., Goris A., Hebrink D.D., Heggarty S., Cunningham S., Alloza I., et al. INFG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes Immun 6 (2005) 153-161
15. Kantarci O.H., Hebrink D.D., Schaefer-Klein J., Sun Y., Achenbach S., Atkinson E.J., et al. Interferon gamma allelic variants: sex biased multiple sclerosis susceptibility and gene expression. Arch Neurol 65 (2008) 349-357
16. Soldan S.S., Alvarez Retuerto A.I., Sicotte N.L., and Voskuhl R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Neuroimmunol 146 (2004) 209-215
17. Pelfrey C.M., Cotleur A.C., Lee J.C., and Rudick R.A. Sex differences in cytokine responses to myelin peptides in multiple sclerosis. J Neuroimmunol 130 (2002) 211-223
18. Nguyen L.T., Ramanathan M., Weinstock-Guttman B., Baier M., Brownscheidle C., and Jacobs L.D. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J Neurol Sci 209 (2003) 93-99
19. Killestein J., Den Drijver B.F., Van der Graaff W.L., Uitdehaag B.M., Polman C.H., and Van Lier R.A. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease. Mult Scler 7 (2001) 145-150
20. Eikelenboom M.J., Killestein J., Uitdehaag B.M., and Polman C.H. Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis. Mult Scler 11 5 (2005) 520-523
21. Palaszynski K.M., Liu H., Loo K.K., and Voskuhl R.R. Estriol treatment ameliorates disease in males with EAE: implications for multiple sclerosis. J Neuroimmunology 149 (2004) 84-89
22. Killestein J., Rep M.H., Meilof J.F., Adèr H.J., Uitdehaag B.M., Barkhof F., et al. Seasonal variation in immune measurements and MRI markers of disease activity in MS. Neurology 58 (2002) 1077-1080
23. Lemire J.M., and Archer D.C. 1, 25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87 (1991) 1103-1107
24. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296 (2006) 2832-2838
25. Munger K.L., Zhang S.M., O'Reilly E., Hernán M.A., Olek M.J., Willett W.C., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 (2004) 60-65
26. Smolders J., Menheere P., Kessels A., Damoiseaux J., and Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14 (2008) 1220-1224
27. van der Mei I.A., Ponsonby A.L., Dwyer T., Blizzard L., Taylor B.V., Kilpatrick T., et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254 (2007) 581-590
28. Woolmore J.A., Stone M., Pye E.M., Partridge J.M., Boggild M., Young C., et al. Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. Mult Scler 13 (2007) 369-375
29. 3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175 (2005) 4119-4126
30. Kragt J., van Amerongen B., Killestein J., Dijkstra C., Uitdehaag B., Polman C.H., et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15 (2009) 9-15
31. Correale J., Ysrraelit M.C., and Gaitán M.I. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132 (2009) 1146-1160